SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (313)3/30/1999 10:21:00 AM
From: aknahow  Respond to of 3158
 
While I doubt Bayer has an interest in XOMA there have been rumors at the rumor mill, that they do. Your post stating an interest in protein therapies would fit the XOMA/BPI platform.

Yes, it would probably fit a lot of other companies also.

Thanks for the post. Not hyping XOMA. Just thinking about location, and protein therapies.



To: Biomaven who wrote (313)3/30/1999 5:13:00 PM
From: LLCF  Respond to of 3158
 
< Bayer plans.>

Boy, they are pretty specific... "protien therapies". Anyone have comments on who would fit that bill? PDLI perked up awfully fast yesterday...

DAK


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News